Lonza and NNIT to Host Free Webinar on MES for the Future – Achieving Pharma 4.0 through Accelerated MES Implementation

Discover how implementation of next-generation Manufacturing Execution Systems (MES) can be optimized and streamlined to pave the way to faster pharma digitalization.

Written byLonza
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Lonza Bioscience Informatics and NNIT will host a free 60-minute webinar to discuss the key requirements of next generation Manufacturing Execution Systems (MES) and how small- and medium-sized companies can overcome critical implementation challenges for accelerated pharma digitalization. Webinar attendees will also have the chance to engage with the expert presenters in a live Q&A session following the webinar.

As digital transformation of pharmaceutical manufacturing becomes critical for companies to ensure compliance and remain competitive, the requirement for a more agile and accelerated approach to implementation of MES is becoming clear. However, MES implementation projects have traditionally been viewed as complex, time and resource intensive, and inaccessible to smaller organizations. In the case of cell and gene therapy (CGT) manufacturing, available systems often need extensive customization to accommodate inherent workflow complexities, further complicating deployment.Lonza has extensive first-hand experience of the challenges facing organizations that have their sights on achieving pharma ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform